Janney Montgomery Scott LLC Has $367,000 Position in Teladoc Health, Inc. (NYSE:TDOC)

Janney Montgomery Scott LLC lowered its holdings in Teladoc Health, Inc. (NYSE:TDOCGet Rating) by 61.8% during the second quarter, Holdings Channel.com reports. The firm owned 10,476 shares of the health services provider’s stock after selling 16,937 shares during the period. Janney Montgomery Scott LLC’s holdings in Teladoc Health were worth $367,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently bought and sold shares of TDOC. PSI Advisors LLC lifted its stake in shares of Teladoc Health by 19.3% during the second quarter. PSI Advisors LLC now owns 1,855 shares of the health services provider’s stock valued at $62,000 after acquiring an additional 300 shares during the period. Quadrant Capital Group LLC lifted its stake in shares of Teladoc Health by 38.5% during the first quarter. Quadrant Capital Group LLC now owns 1,123 shares of the health services provider’s stock valued at $81,000 after acquiring an additional 312 shares during the period. Vestmark Advisory Solutions Inc. lifted its stake in shares of Teladoc Health by 10.1% during the first quarter. Vestmark Advisory Solutions Inc. now owns 3,664 shares of the health services provider’s stock valued at $264,000 after acquiring an additional 337 shares during the period. MAI Capital Management lifted its stake in shares of Teladoc Health by 5.1% during the second quarter. MAI Capital Management now owns 6,928 shares of the health services provider’s stock valued at $230,000 after acquiring an additional 337 shares during the period. Finally, Benjamin Edwards Inc. lifted its stake in shares of Teladoc Health by 50.9% during the first quarter. Benjamin Edwards Inc. now owns 1,011 shares of the health services provider’s stock valued at $73,000 after acquiring an additional 341 shares during the period. Institutional investors and hedge funds own 92.46% of the company’s stock.

Teladoc Health Stock Up 7.5 %

NYSE:TDOC opened at $33.31 on Monday. The company has a debt-to-equity ratio of 0.25, a quick ratio of 2.99 and a current ratio of 3.13. The company has a market cap of $5.39 billion, a PE ratio of -0.54 and a beta of 0.97. Teladoc Health, Inc. has a 52-week low of $23.08 and a 52-week high of $137.96. The stock has a 50-day simple moving average of $27.84 and a 200 day simple moving average of $32.68.

Teladoc Health (NYSE:TDOCGet Rating) last posted its quarterly earnings data on Wednesday, October 26th. The health services provider reported ($0.45) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.59) by $0.14. The business had revenue of $611.40 million during the quarter, compared to the consensus estimate of $609.45 million. Teladoc Health had a negative return on equity of 2.47% and a negative net margin of 424.40%. On average, sell-side analysts expect that Teladoc Health, Inc. will post -1.43 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several equities analysts have recently issued reports on the company. StockNews.com assumed coverage on Teladoc Health in a research note on Wednesday, October 12th. They set a “sell” rating on the stock. SVB Leerink cut their price target on Teladoc Health from $35.00 to $34.00 and set a “market perform” rating on the stock in a research note on Thursday, July 28th. The Goldman Sachs Group lowered Teladoc Health from a “buy” rating to a “neutral” rating and cut their price target for the company from $55.00 to $36.00 in a research note on Thursday, July 28th. Truist Financial cut their target price on Teladoc Health from $35.00 to $29.00 and set a “hold” rating on the stock in a research note on Friday, October 21st. Finally, Royal Bank of Canada cut their target price on Teladoc Health from $53.00 to $35.00 in a research note on Wednesday, September 28th. One analyst has rated the stock with a sell rating, twenty-four have given a hold rating and five have assigned a buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and an average target price of $54.93.

Insider Buying and Selling

In other Teladoc Health news, SVP Daniel Trencher sold 1,000 shares of the firm’s stock in a transaction that occurred on Wednesday, August 17th. The stock was sold at an average price of $37.50, for a total value of $37,500.00. Following the completion of the transaction, the senior vice president now directly owns 26,408 shares in the company, valued at $990,300. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. In other Teladoc Health news, SVP Daniel Trencher sold 1,000 shares of the firm’s stock in a transaction that occurred on Wednesday, August 17th. The stock was sold at an average price of $37.50, for a total value of $37,500.00. Following the completion of the transaction, the senior vice president now directly owns 26,408 shares in the company, valued at $990,300. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, insider Arnnon Geshuri sold 4,098 shares of the firm’s stock in a transaction that occurred on Friday, August 26th. The shares were sold at an average price of $34.27, for a total value of $140,438.46. Following the completion of the transaction, the insider now owns 76,182 shares of the company’s stock, valued at $2,610,757.14. The disclosure for this sale can be found here. Over the last three months, insiders sold 7,845 shares of company stock worth $253,814. 1.55% of the stock is owned by corporate insiders.

Teladoc Health Profile

(Get Rating)

Teladoc Health, Inc engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. Its portfolio of services and solutions covers medical subspecialties from non-urgent, episodic needs like flu and upper respiratory infections, to chronic, complicated medical conditions like cancer and congestive heart failure.

Featured Stories

Want to see what other hedge funds are holding TDOC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teladoc Health, Inc. (NYSE:TDOCGet Rating).

Institutional Ownership by Quarter for Teladoc Health (NYSE:TDOC)

Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.